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Not only are workers in the sawmill and other
wood industries exposed to a variety of nat-
ural chemicals, fungi, and bacteria in raw
barks and woods, they are also exposed rou-
tinely to myriad and combinations of syn-
thetic chemicals used in these wood and
wood-related enterprises. As an example, in a
paper on sawmill workers occupationally
exposed to chlorophenate fungicides (1), no
particular mention was made of experimental
carcinogenicity studies of several chemicals
that have been found to be pervasive in
sawmill wood-working environs and the
wood preservatives industry. Among many
chemicals, these typically include chlorophe-
nols, likely containing dioxin contaminants;
creosotes; certain ﬂame retardants; formalde-
hyde; metal salts (arsenic, chromium, copper);
phenol; and various pesticides and fungicides.
Without a doubt, most workers in the wood
industries are exposed routinely and repeti-
tiously to both natural and synthetic chemi-
cals, and to wood and other dusts as well. 
In this commentary, I summarize carcino-
genesis results for several chemicals used in
the wood industry, as well as for wood dust.
Findings from experimental carcinogenesis
studies in animals are not only important for
ascertaining or conﬁrming carcinogenic risks
to humans (2–5) but for planning and per-
forming etiologic epidemiologic studies as
well (6). After all, we know that experimental
carcinogenicity data are the prime indicators
of potential carcinogenic hazards to humans
(7–11). We also recognize that for all human
carcinogens that have been tested in animals,
there is a perfect correlation (2,8,12–14), and,
significantly, for nearly one-third of the
known human carcinogens, positive carcino-
genesis ﬁndings in animals were ﬁrst identi-
fied in experimental animals and only
subsequently observed in humans (15,16).
This alone surely represents a failure of the
public health system, and one hopes that this
will happen not at all or less so in the future.
Of course, for some chemicals such as drugs
and pesticides, toxicology studies are done
typically before widespread human exposure
occurs. Yet, even for chemicals in those two
categories, they are often marketed despite
having positive animal carcinogenicity or
other toxicology information. 
Using animal and human chemical car-
cinogenesis data and evaluative results, cer-
tain chemicals used in the wood industry
should be considered logical and potential
causal sources of occupational cancers. For
example, studying children whose parents
work in the sawmill industry, Heacock et al.
(1) found only a small, nonsigniﬁcant associ-
ation of childhood cancers for offspring of
male workers exposed to chlorophenol fungi-
cides and their dioxin contaminants. Hence,
their “analyses provide little evidence to sup-
port a relationship between the risk of child-
hood cancer and paternal occupational
exposure to chlorophenate fungicides in
British Columbian sawmills” (1). However,
Mirabelli et al. (17) did find an association
between occupational exposure to chlorophe-
nol and the risk of nasal and nasopharyngeal
cancers in U.S. men 30–60 years of age.
In 1987, the International Agency for
Research on Cancer (IARC) indicated that
information on the occurrence of cancer in
lumber and sawmill workers was limited
(18). Speciﬁcally, nasal tumors, lymphomas
and leukemias, and soft-tissue sarcomas have
been linked with work in the lumber and
sawmill industries, but the ﬁndings were con-
sidered inconsistent (18,19). Subsequently,
the data on sawmill workers and cancer have
become more abundant. In contrast, most of
the available cohort and case–control studies
of cancer of the nasal cavities and paranasal
sinuses have shown increased risks associated
with exposure to wood dust (20), and occu-
pational exposures to wood dust are consid-
ered carcinogenic to humans. Moreover,
employment in the furniture- and cabinet-
making industry has been causally associated
with nasal adenocarcinoma, as well as with an
increased risk of other nasal cancers (18). 
Wood Dust
Wood dust, generated in the processing of
wood for diverse uses, is a complex substance
and varies considerably according to species
of tree and even geography. Composed
mainly of cellulose, polyoses, and lignin,
wood dust may contain a variety of nonpolar
organic extractives (fatty acids, resin acids,
waxes, alcohols, terpenes, sterols, steryl esters,
and glycerols), polar organic extractives (tan-
nins, ﬂavonoids, quinones, and lignans), and
water-soluble extractives (carbohydrates, alka-
loids, proteins, and inorganic material) (20).
Various chemicals are added to wood to
impart hardiness, longer life, and resistance
to pests, humidity, and other means of dete-
rioration. Some of these added agents are the
subjects of this communication. As an exam-
ple, within the furniture-manufacturing
industry, exposure may occur not only to
dusts but to solvents and formaldehyde in
glues and surface coatings. Manufacture of
plywood and particle board may entail expo-
sure to formaldehyde, solvents, phenol, wood
preservatives, and engine exhausts. Exposures
to chemicals in industries where other wood
products are manufactured vary but are con-
sidered similar to those in the furniture-man-
ufacturing industry. 
Whereas the experimental studies of
wood dust are considered inadequate for
evaluation of carcinogenic risk, wood dust is
carcinogenic to humans, causing cancer of
the nasal cavities and paranasal sinuses
(20–22). According to IARC, “The excess [in
cancer] appears to be attributable to wood
dust per se, rather than to other exposures in
the workplace, since the excess was observed
in various countries during different periods
and among different occupational groups,
and because direct exposures to other chemi-
cals do not produce relative risks of the mag-
nitude associated with exposure to wood
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further substantiated and provide strong
support for the association between exposure
to wood dust in a variety of occupations and
the risk of sino-nasal adenocarcinoma,
although less so for the occurrence of squa-
mous cell carcinomas (23). Further, there is
suggestive but inconclusive evidence for a
causal role of occupational exposure to wood
dust in cancers of the nasopharynx. Workers
exposed to wood dust may have an excess
risk of nasopharyngeal cancer and multiple
myeloma in addition to sino-nasal cancer.
Possible limitations tend to obscure relation-
ships, rather than create false positive find-
ings (21). Excesses of other cancers,
including lung and stomach, have been
reported among persons employed in wood
industries or occupationally exposed to
wood dust, but not as consistently or
unequivocally.
In this paper, brieﬂy presented in alpha-
betical order, are experimental carcinogene-
sis findings, with some remarks on human
evidence, on several chemicals used or




p-dioxin (TCDD). More details on animal
studies regarding exposure levels, body
weights and mortality, and incidence rates
of tumors can be found in the cited refer-
ences, as can the epidemiologic evidence. 
Arsenic
Arsenic has been long known to cause cancer
in humans (24,25) and has been correlated
convincingly with cancers of the skin, lungs,
liver, kidney, and urinary bladder (7,26,27).
In laboratory animals the ﬁndings have been
considered less than adequate in that few
studies have been done on arsenic and
arsenic compounds, speciﬁcally arsenic triox-
ide, a common form of human exposures
(28,29).
However, the two major metabolites of
arsenics, DMAA (dimethylarsinic acid) and
MMAA (monomethylarsinic acid), have been
evaluated, and both have been shown to cause
or promote cancer in rodents (28–32).
Bioassays have been reported that show
DMAA (cacodylic acid), typical of organic
arsenicals, induced cancer of the urinary blad-
der in rodents, a site concordant with that
seen in humans (28), and DMAA also pro-
moted tumors of the urinary bladder as well
as of several other organs: kidney, lung, liver,
skin (fibrosarcomas), and thyroid glands in
rats (30–33). MMAA promoted tumors of
the urinary bladder in rats (30). This clearly
indicates that humans and rodents possess a
similar tendency to develop shared-site
tumors when exposed to arsenicals.
Chromated-Copper-Arsenate 
CCA is used worldwide for wood preserva-
tion, and it contains varying percentages of
mixtures of arsenic pentoxide, chromium
trioxide, and cupric oxide. Hexavalent
chromium and arsenic trioxide are carcino-
genic to animals and to humans (7,18,28),
with chromium typically causing lung
tumors and arsenic-inducing cancer in several
sites (see “Arsenic”). No carcinogenicity stud-
ies on CCA per se were found, and no ade-
quate reports on the carcinogenicity of copper
or copper salts were located. Copper 8-
hydroxyquinoline has been studied in animals
but is considered deﬁcient for evaluation. 
Creosotes
Creosotes have worldwide use as wood
preservatives. Creosotes contain a collection
of polycyclic aromatic hydrocarbons.
Potential hazards come from inhalation
exposures and considerable opportunity for
exposures to the skin. Creosotes, creosote
oils, and anthracene oils were tested for car-
cinogenicity in mice by skin application,
producing skin tumors, including carcino-
mas. One of the creosotes also produced lung
tumors in mice after skin application (18,34).
In a number of case reports, the develop-
ment of skin cancer in workers exposed to
creosote is described. Cutaneous epithelioma
occurred in workers handling creosotes or
creosoted wood during timber treatment. A
mortality analysis of workers in many occu-
pations indicated an increased risk of scrotal
cancer for creosote-exposed brickmakers
(18,34–38). This, of course, was the first
identiﬁed chemical-caused occupational can-
cer, as described in 1775 by the surgeon Sir
Percival Pott that chimney sweeps developed
scrotal cancer as a direct consequence of
exposure to a deﬁned “substance” (soots) in
their occupation (39).  Environmentally, ﬁsh
exposed in a creosote-polluted harbor (40)
and river (41) developed liver tumors.
Formaldehyde
World production of formaldehyde is about
15 million metric tons, and this gas is used
mainly in the production of phenolic, urea,
melamine, and acetal resins, which have wide
use in the production of adhesives and
binders in the wood, plastics, textiles, leather,
and related industries (20,42). Formaldehyde
is used also as an aqueous solution disinfec-
tant (formalin), embalming ﬂuid, and preser-
vative in many applications, particularly by
anatomists and pathologists for tissues and
organs. Formaldehyde occurs naturally in
most living systems and in the environment.
Nonoccupational sources include vehicle
emissions, building materials, food, tobacco
smoke, and use as a disinfectant. Several mil-
lion people are exposed occupationally to
formaldehyde in industrialized countries
alone. Continuous relatively high-level expo-
sures frequently exceeding 1 mg/m3 have
been measured in particle-board mills, during
the varnishing of furniture and wooden
floors, in foundries, during the finishing of
textiles, and in fur processing. Other expo-
sures include formaldehyde-based glues and
varnishes, solvents, wood dust, wood preserv-
atives, and textile ﬁnishing agents (20,42). 
In experimental animals, exposure to
formaldehyde by inhalation causes squa-
mous-cell carcinomas of the nasal cavities. In
drinking water studies, tumors were induced
in the forestomach and gastrointestinal tract,
as were leukemias (20,42–44). In humans,
formaldehyde has been associated with
nasopharyngeal cancers, and with squamous-
cell carcinoma of the nasal cavities and
paranasal sinuses (20,42,45–49). Further
long-term occupational studies are obvious,
including substantiation of cancers of the
brain in anatomists and embalmers. 
Pentachlorophenol
Pentachlorophenol (PCP), a member of the
polychlorophenols chemical family, is a bio-
cide used primarily as a wood preservative
and as a herbicide, algaecide, defoliant, ger-
micide, fungicide, and molluscicide.
Toxicology and carcinogenesis studies of
PCP were conducted by feeding diets con-
taining a technical-grade composite or
Dowicide EC-7 (a commercial grade with
lower levels of contaminants) to groups of
mice (50,51). Both technical PCP- and EC-
7-related neoplasms were observed in three
organs/systems: liver, adrenal gland medulla,
and vascular endothelium (hemangiosarco-
mas). Results suggest that the carcinogenic
responses were due almost exclusively to
PCP, with possibly a minimal potentiating
influence by contaminants, in particular
hexachlorodibenzo-p-dioxins (52). Two-year
feed studies in rats exposed to 99% pure
PCP showed increased incidences of
mesothelioma of the tunica vaginalis and
nasal squamous cell carcinoma in male but
not female rats (53,54). 
Pentachlorophenol induced skin papillo-
mas in the Tg.AC transgenic mouse model
and not in p53+/- mice (55). Using the
mouse cancer data (50), Reigner et al. (56)
reported that risks of cancer for lifetime
exposure to PCP are from 20 to 140 times
greater than the acceptable extra risk (10-6).
IARC considers that there is sufficient evi-
dence in experimental animals for the car-
cinogenicity of PCP, whereas there is limited
evidence in humans for the carcinogenicity of
combined exposures to polychlorophenols or
to their sodium salts (57,58). Epidemiologic
studies have shown significant associations
with several types of cancer, but the most
Commentary • Huff
210 VOLUME 109 | NUMBER 3 | March 2001 • Environmental Health Perspectivesconsistent ﬁndings have been for soft-tissue
sarcoma and non-Hodgkin lymphoma. 
Phenol
Phenol, ranked in the top 50 chemicals pro-
duced in the United States with roughly 4–5
billion pounds, is used in the production of
bisphenol A, caprolactam, phenolic resins
(phenol formaldehyde), wood preservatives
(PCP), chlorophenols, and several alkylphe-
nols and xylenols (59,60). Phenol is also used
in disinfectants and antiseptics. Occupational
exposure to phenol has been reported during
its production and use, as well as in the use of
phenolic resins in the wood products indus-
try. There is suggestive (one study) but
inconsistent evidence for lung cancer risk
among woodworkers exposed to phenol (60). 
In male rats treated with phenol in drink-
ing water, increased incidences of leukemia,
pheochromocytomas of the adrenal gland,
and c-cell carcinomas of the thyroid gland
were found; however; these occurred only in
the lower-dose group and not in high-dose
male rats or in female rats or mice (61,62).
Other than the data showing a carcinogenic
effect of phenol in male rats, an explanation
for these ﬁndings has not been forthcoming.
Phenol has been shown to be a promoter in
mouse skin exposure studies (59). Using
Syrian hamster embryo (SHE) cells, phenol
induced morphologic transformations, gene
mutations at two loci (both ouabain-resistant
and 6-thioguanine-resistant mutant frequen-
cies were increased), chromosomal aberra-
tions, sister chromatid exchanges, and
unscheduled DNA synthesis (63). Obviously
phenol is genotoxic. 
Polychlorophenols
Di-, tri-, tetra-, and pentachlorophenols (see
PCP above) might all be used in the wood
industry or are products of other chlorophe-
nols. Exposures to chlorophenols and their
salts have occurred in their production, in the
making of certain phenoxy acid herbicides,
and in the wood, textile, and tannery indus-
tries (58). 2,4,5-Tri- and tetracholorphenols
have not been tested adequately for carcino-
genicity in animals. 2,4-Dichlorophenol, at
exposures up to 10,000 ppm in the diet for 2
years, did not cause any increases in tumors
in rats or mice (64). Interestingly, mononu-
clear cell leukemias in rats and lymphomas in
mice were decreased in these studies.
Conversely, 2,4,6-trichlorophenol induced
mononuclear cell leukemias in male rats and
liver tumors in mice (65). 
Several case–control and cohort studies
have shown significant associations with 
several types of cancer, with the most consis-
tent findings being for soft-tissue sarcoma
and non-Hodgkin lymphoma (58). A possi-
ble confounding effect of polychlorinated
dibenzo-p-dioxins (see below), which occur
as contaminants in chlorophenols, cannot be
fully excluded. In humans, controlling for
estimated formaldehyde and wood dust
exposure did not alter the correlation
between cancer and exposure, as much of the
estimated chlorophenol exposure was among
machinists (17). These ﬁndings support the
hypothesis that occupational exposure to
chlorophenol is a risk factor for nasal and
nasopharyngeal cancer, although the role of




Dioxins are everywhere. They have been
long known as being carcinogenic to labora-
tory animals, causing a wide range of tumors
(66–69), and are now confirmed as being
carcinogenic to humans (7,67–72). TCDD
causes cancer in multiple species, multiple
strains, both sexes, and in multiple organs
and tissues (66–69). TCDD causes cancer
by multiple routes, various durations of
exposure, and ranges of exposure concentra-
tions (66). Tumor responses in both animals
and humans are varied and include (in
decreasing order of conﬁdence) total tumors,
lung cancer, soft-tissue sarcoma, non-
Hodgkin lymphoma, breast cancer, digestive
system cancers, multiple myeloma, skin, and
thyroid gland in humans; and (alphabeti-
cally) adrenal glands, hematopoietic system
(lymphomas), liver, lung, mouth (tongue
and hard palate), nasal turbinates (nose),
skin, and thyroid gland in animals. Clearly,
several dioxin-induced tumor sites are com-
mon in both humans and in animals.
TCDD is another instance where the car-
cinogenesis findings were first identified in
animals and only later in humans (15).
Summary
Certain chemicals used in the wood industry
are carcinogenic to experimental animals and
to humans. All of the chemicals reviewed in
this commentary have been shown or
reported to cause cancer. Carcinogenic organ
sites are varied and are frequently the same in
animals and in humans. Working in the
wood industries certainly entails excess risks
of cancers, among other diseases and work-
place injuries. Of course, a key to preventing
occupationally and environmentally associ-
ated cancers, such as in the wood industries,
is avoiding exposures to chemicals, and in
particular chemicals known to cause cancer
in animals or/and humans (73). In the wood
industry, as I am convinced is the same in
most industries and for many cancers, etio-
logic factors are rarely single discrete agents,
but are most likely associated with combina-
tional effects as being the causes of a majority
of cancers (74). This includes not only chem-
ical exposures but also environmental condi-
tions, individual genetic susceptibilities, and
lifestyles. Unfortunately, however, animal
bioassays, epidemiology studies, risk assess-
ments, and regulatory actions typically center
on individual agents. Almost singularly,
IARC evaluates occupations, workplaces, and
manufacturing processes for potential cancer
causation. More of these types of composite
evaluations need to be done. Today more
than ever, regarding chemicals and cancer,
preventing or reducing cancer incidences and
mortalities depends significantly and neces-
sarily on limiting or avoiding exposure to all
known occupational, environmental, and
animal carcinogens (75,76). Why would we
think otherwise?
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